top of page

NEWS
Announcements & Discoveries
UNC researchers report protective effects of parmodulins in sickle cell disease models
A collaborative team led by Prof. Erica Sparkenbaugh from the Univ. of North Carolina Blood Research Center reported at the 64th American...
Dec 12, 2022
Peter Suzdak, Ph.D. joins as consultant
Peter Suzdak, Ph.D. has joined Function Therapeutics, Inc. as a consultant. Dr. Suzdak has deep scientific and management successes in...
Nov 12, 2022
ML161 greatly improves kidney function in a mouse model of diabetic kidney disease
Drs. Shrey Kohli, Berend Isermann, and team report in Nature Communications that the PAR1-targeting parmodulin ML161 (aka Parmodulin 2)...
Sep 29, 2022
For News Inquiries

bottom of page
